Aethlon Medical Inc Cash Flow Conversion Efficiency
Aethlon Medical Inc cash flow conversion efficiency. Based on the latest financial reports, Aethlon Medical Inc (AEMD) has a cash flow conversion efficiency ratio of -364.766x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.90 Billion) by net assets ($5.20 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Aethlon Medical Inc (1997–2026)
Cash flow conversion efficiency of Aethlon Medical Inc from 1997 to 2026. This chart illustrates how Aethlon Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Aethlon Medical Inc share price for real-time trading data and today's change.
Aethlon Medical Inc Cash Flow Conversion Ratio Explained
Aethlon Medical Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Aethlon Medical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Aethlon Medical Inc ranked by their cash flow conversion efficiency. Also see Aethlon Medical Inc market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
MultiMetaVerse Holdings Limited
NASDAQ:MMV
|
0.007x |
|
GGX Gold Corp
V:GGX
|
0.054x |
|
INCUVO S.A. ZY -50
F:68X
|
0.135x |
|
COPPERCORP RESOURCES INC.
F:NU0
|
-0.636x |
|
Stelmine Canada Ltd
V:STH
|
0.019x |
|
Rover Metals Corp
V:ROVR
|
-0.003x |
|
Metavisio (Thomson Computing)
PA:ALTHO
|
-0.002x |
|
Alligator Bioscience AB
ST:ATORX
|
-4.204x |
Annual Cash Flow Conversion Efficiency for Aethlon Medical Inc (1997–2026)
The table below shows the annual cash flow conversion efficiency of Aethlon Medical Inc from 1997 to 2026. Review Aethlon Medical Inc free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | $4.89 Million | $-7.00 Million | -1.432x | +4.02% |
| 2025-03-31 | $5.12 Million | $-7.65 Million | -1.492x | +15.06% |
| 2024-03-31 | $5.77 Million | $-10.13 Million | -1.757x | -151.91% |
| 2023-03-31 | $15.06 Million | $-10.51 Million | -0.697x | -21.32% |
| 2022-03-31 | $16.99 Million | $-9.77 Million | -0.575x | +21.03% |
| 2021-03-31 | $9.29 Million | $-6.76 Million | -0.728x | -29.93% |
| 2020-03-31 | $9.28 Million | $-5.20 Million | -0.560x | +70.00% |
| 2019-03-31 | $2.30 Million | $-4.29 Million | -1.867x | -188.08% |
| 2018-03-31 | $6.03 Million | $-3.91 Million | -0.648x | +88.99% |
| 2017-03-31 | $595.41K | $-3.51 Million | -5.888x | -104.33% |
| 2016-03-31 | $1.50 Million | $-4.33 Million | -2.882x | +62.83% |
| 2015-03-31 | $651.38K | $-5.05 Million | -7.752x | -5438.35% |
| 2014-03-31 | $-14.73 Million | $-2.14 Million | 0.145x | -36.73% |
| 2013-03-31 | $-9.14 Million | $-2.10 Million | 0.230x | +15.87% |
| 2012-03-31 | $-9.30 Million | $-1.84 Million | 0.198x | -39.86% |
| 2011-03-31 | $-5.98 Million | $-1.97 Million | 0.329x | -26.67% |
| 2010-03-31 | $-4.40 Million | $-1.98 Million | 0.449x | -0.19% |
| 2009-03-31 | $-3.95 Million | $-1.78 Million | 0.450x | -28.95% |
| 2008-03-31 | $-3.32 Million | $-2.10 Million | 0.633x | +161.32% |
| 2007-03-31 | $-7.09 Million | $-1.72 Million | 0.242x | -73.08% |
| 2006-03-31 | $-1.76 Million | $-1.58 Million | 0.900x | +77.10% |
| 2005-03-31 | $-3.07 Million | $-1.56 Million | 0.508x | +242.85% |
| 2004-03-31 | $-3.66 Million | $-542.06K | 0.148x | +4.50% |
| 2003-03-31 | $-3.63 Million | $-514.50K | 0.142x | -69.05% |
| 2002-03-31 | $-2.20 Million | $-1.01 Million | 0.458x | +41.19% |
| 2001-03-31 | $-2.47 Million | $-800.67K | 0.325x | -65.90% |
| 2000-03-31 | $-713.05K | $-678.93K | 0.952x | +446.46% |
| 1999-03-31 | $-704.50K | $-122.75K | 0.174x | -88.46% |
| 1998-03-31 | $-1.23K | $-1.85K | 1.510x | +261.57% |
| 1997-03-31 | $2.37K | $-2.22K | -0.935x | -- |
About Aethlon Medical Inc
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states. The company was founded in 1984 and is based in San Diego, California.